Baseline demographic and clinical characteristics in intravenous vs. intracoronary epinephrine cohorts
| . | Cohort . | . | |
|---|---|---|---|
| Characteristics . | Intravenous epinephrine . | Intracoronary epinephrine . | P-value . |
| Age, years, mean ± SD | 61.01 ± 9.27 | 60.06 ± 10.29 | 0.557 |
| Female, n (%) | 41 (37.27%) | 15 (28.85%) | 0.292 |
| BMI, mean ± SD | 29.4 ± 3.1 | 30.4 ± 2.52 | 0.107 |
| Diabetes, n (%) | 83 (75.45%) | 38 (73.08%) | 0.745 |
| Hypertension, n (%) | 59 (53.64%) | 26 (50%) | 0.665 |
| Active smoking, n (%) | 49 (44.55%) | 26 (50%) | 0.516 |
| Dyslipidaemia, n (%) | 56 (50.91%) | 23 (44.23%) | 0.427 |
| Chronic obstructive pulmonary disease, n (%) | 9 (8.18%) | 4 (7.69%) | 0.915 |
| Asthma, n (%) | 2 (1.82%) | 1 (1.92%) | 0.963 |
| Chronic kidney disease, n (%) | 24 (21.8%) | 10 (19.2%) | 0.706 |
| Chronic liver disease, n (%) | 1 (0.91%) | 3 (5.77%) | 0.063 |
| Prior stroke, n (%) | 11 (10%) | 5 (9.62%) | 0.939 |
| Prior coronary artery disease, n (%) | 51 (46.36%) | 29 (55.77%) | 0.264 |
| Prior myocardial infarction, n (%) | 3 (2.73%) | 2 (3.85%) | 0.701 |
| Prior coronary intervention, n (%) | 8 (7.27%) | 3 (5.77%) | 0.723 |
| Prior coronary artery bypass, n (%) | 5 (4.55%) | 3 (5.77%) | 0.737 |
| Left ventricular ejection fraction, mean ± SD | 50.9 ± 9.2 | 48.2 ± 13.1 | 0.132 |
| . | Cohort . | . | |
|---|---|---|---|
| Characteristics . | Intravenous epinephrine . | Intracoronary epinephrine . | P-value . |
| Age, years, mean ± SD | 61.01 ± 9.27 | 60.06 ± 10.29 | 0.557 |
| Female, n (%) | 41 (37.27%) | 15 (28.85%) | 0.292 |
| BMI, mean ± SD | 29.4 ± 3.1 | 30.4 ± 2.52 | 0.107 |
| Diabetes, n (%) | 83 (75.45%) | 38 (73.08%) | 0.745 |
| Hypertension, n (%) | 59 (53.64%) | 26 (50%) | 0.665 |
| Active smoking, n (%) | 49 (44.55%) | 26 (50%) | 0.516 |
| Dyslipidaemia, n (%) | 56 (50.91%) | 23 (44.23%) | 0.427 |
| Chronic obstructive pulmonary disease, n (%) | 9 (8.18%) | 4 (7.69%) | 0.915 |
| Asthma, n (%) | 2 (1.82%) | 1 (1.92%) | 0.963 |
| Chronic kidney disease, n (%) | 24 (21.8%) | 10 (19.2%) | 0.706 |
| Chronic liver disease, n (%) | 1 (0.91%) | 3 (5.77%) | 0.063 |
| Prior stroke, n (%) | 11 (10%) | 5 (9.62%) | 0.939 |
| Prior coronary artery disease, n (%) | 51 (46.36%) | 29 (55.77%) | 0.264 |
| Prior myocardial infarction, n (%) | 3 (2.73%) | 2 (3.85%) | 0.701 |
| Prior coronary intervention, n (%) | 8 (7.27%) | 3 (5.77%) | 0.723 |
| Prior coronary artery bypass, n (%) | 5 (4.55%) | 3 (5.77%) | 0.737 |
| Left ventricular ejection fraction, mean ± SD | 50.9 ± 9.2 | 48.2 ± 13.1 | 0.132 |
Baseline demographic and clinical characteristics in intravenous vs. intracoronary epinephrine cohorts
| . | Cohort . | . | |
|---|---|---|---|
| Characteristics . | Intravenous epinephrine . | Intracoronary epinephrine . | P-value . |
| Age, years, mean ± SD | 61.01 ± 9.27 | 60.06 ± 10.29 | 0.557 |
| Female, n (%) | 41 (37.27%) | 15 (28.85%) | 0.292 |
| BMI, mean ± SD | 29.4 ± 3.1 | 30.4 ± 2.52 | 0.107 |
| Diabetes, n (%) | 83 (75.45%) | 38 (73.08%) | 0.745 |
| Hypertension, n (%) | 59 (53.64%) | 26 (50%) | 0.665 |
| Active smoking, n (%) | 49 (44.55%) | 26 (50%) | 0.516 |
| Dyslipidaemia, n (%) | 56 (50.91%) | 23 (44.23%) | 0.427 |
| Chronic obstructive pulmonary disease, n (%) | 9 (8.18%) | 4 (7.69%) | 0.915 |
| Asthma, n (%) | 2 (1.82%) | 1 (1.92%) | 0.963 |
| Chronic kidney disease, n (%) | 24 (21.8%) | 10 (19.2%) | 0.706 |
| Chronic liver disease, n (%) | 1 (0.91%) | 3 (5.77%) | 0.063 |
| Prior stroke, n (%) | 11 (10%) | 5 (9.62%) | 0.939 |
| Prior coronary artery disease, n (%) | 51 (46.36%) | 29 (55.77%) | 0.264 |
| Prior myocardial infarction, n (%) | 3 (2.73%) | 2 (3.85%) | 0.701 |
| Prior coronary intervention, n (%) | 8 (7.27%) | 3 (5.77%) | 0.723 |
| Prior coronary artery bypass, n (%) | 5 (4.55%) | 3 (5.77%) | 0.737 |
| Left ventricular ejection fraction, mean ± SD | 50.9 ± 9.2 | 48.2 ± 13.1 | 0.132 |
| . | Cohort . | . | |
|---|---|---|---|
| Characteristics . | Intravenous epinephrine . | Intracoronary epinephrine . | P-value . |
| Age, years, mean ± SD | 61.01 ± 9.27 | 60.06 ± 10.29 | 0.557 |
| Female, n (%) | 41 (37.27%) | 15 (28.85%) | 0.292 |
| BMI, mean ± SD | 29.4 ± 3.1 | 30.4 ± 2.52 | 0.107 |
| Diabetes, n (%) | 83 (75.45%) | 38 (73.08%) | 0.745 |
| Hypertension, n (%) | 59 (53.64%) | 26 (50%) | 0.665 |
| Active smoking, n (%) | 49 (44.55%) | 26 (50%) | 0.516 |
| Dyslipidaemia, n (%) | 56 (50.91%) | 23 (44.23%) | 0.427 |
| Chronic obstructive pulmonary disease, n (%) | 9 (8.18%) | 4 (7.69%) | 0.915 |
| Asthma, n (%) | 2 (1.82%) | 1 (1.92%) | 0.963 |
| Chronic kidney disease, n (%) | 24 (21.8%) | 10 (19.2%) | 0.706 |
| Chronic liver disease, n (%) | 1 (0.91%) | 3 (5.77%) | 0.063 |
| Prior stroke, n (%) | 11 (10%) | 5 (9.62%) | 0.939 |
| Prior coronary artery disease, n (%) | 51 (46.36%) | 29 (55.77%) | 0.264 |
| Prior myocardial infarction, n (%) | 3 (2.73%) | 2 (3.85%) | 0.701 |
| Prior coronary intervention, n (%) | 8 (7.27%) | 3 (5.77%) | 0.723 |
| Prior coronary artery bypass, n (%) | 5 (4.55%) | 3 (5.77%) | 0.737 |
| Left ventricular ejection fraction, mean ± SD | 50.9 ± 9.2 | 48.2 ± 13.1 | 0.132 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
